My scholarly work spans issues in research and clinical ethics, as well as consumer applications of medical technologies. In particular, I'm interested in ethical questions concerning the brain. Topics I've worked on include ethical issues around digital behavioral technologies, disorders of consciousness, organ transplantation, and novel "human brain surrogates" (e.g., cerebral organoids).


2013: PhD in Philosophy (Stanford University)

2006: MSc in The Evolution of Language and Cognition (University of Edinburgh)

2004: BA in Philosophy (Brown University)


Kreitmair, K. (2023) “Consciousnessand the Ethics of Human Brain Organoid Research”, Cambridge Quarterly ofHealthcare Ethics, [FIRST VIEW].

Kreitmair, K. (2023) “Mobile HealthTechnology and Empowerment”, Bioethics, [EARLY VIEW].

Kreitmair, K. (2023) “Why We StillNeed a Substantive Determination of Death”, American Journal of Bioethics,23 (2), 55-57.

Kreitmair, K. (2021) “Medical Ethics,Moral Courage, and the Embrace of Fallibility”, Academic Medicine,96(12), 1630-1633.

Greely, H, and Kreitmair, K. (2021) “Should Cerebral Organoids be Used for Research if They Have the Capacity forConsciousness?”, Cambridge Quarterly of Healthcare Ethics: ClinicalNeuroethics, 30(4), 575-584.

Kreitmair, K. (2021) “Digital Behavioral Technology,Deep Learning, and Self-Optimization”, in Fabrice Jotterand, Marcello Ienco,Liang Mingyu (eds) Ethics of Artificial Intelligence in Brain and MentalHealth, Springer Series.

Martinez, N., Dasgupta, I., Carter, A., Chandler, J. Kellmeyer,P., Kreitmair, K. Weiss, A, Cabrera, L. (2020) “Ethics of Digital MentalHealth During COVID-19: Crisis and Opportunities”, JMIR mental health,7(12), e23776.

Kreitmair, K. (2019) “Dimensions of Ethical of Direct-to-Consumer Neurotechnologies”, American Journal ofBioethics – Neuroscience, 10 (4), 152-166.

Kreitmair, K. (2019) “Response to Open PeerCommentaries on ’Ethical Dimensions of Direct-to-Consumer Neurotechnologies’”, AmericanJournal of Bioethics – Neuroscience, 10 (4), W1-W3.

Kreitmair, K. (2019) “Neuroprosthetic Speech:Pragmatics, Norms, and Self-Fashioning”, Cambridge Quarterly of HealthcareEthics: Clinical Neuroethics, 28 (4), 671-676. [P]

EmergingIssues Task Force, International Neuroethics Society: Kellmeyer, P., Chandler,J., Cabrera, L., Carter, A., Kreitmair, K., Weiss, A., and Illes, J.(2019) “Neuroethics at 15: The Current and Future Environment for Neuroethics”,American Journal of Bioethics – Neuroscience, 10 (3), 104-110.

Kreitmair, K., and Magnus, D. (2019)“Citizen Science and Gamification”, Hastings Center Report, 49 (2),40-46. [P]

Martinez, N., and Kreitmair, K. (2018)“Ethical Issues for Direct-to-ConsumerDigital Psychotherapy Apps: Addressing Accountability, Data Protection, andConsent”, JMIR Mental Health, 5(2), e32.

Kreitmair, K. (2018) “Phenomenological Considerationsof Sex-Tracking Technology”, American Journal of Bioethics, 18 (2), 31-33.

Kreitmair,K.,and Cho, M. (2017) “The Neuroethical Future of Wearables and Mobile HealthTechnology” in Judy Illes (ed) Neuroethics:Anticipating the Future, Second Edition, Oxford University Press.

Kreitmair,K.(2017)Two Concerns RegardingSubjectively Perceived Self-Estrangement”, AmericanJournal of Bioethics – Neuroscience, 8 (2), 124-125.

Kreitmair,K., Magnus,D., and Cho, M. (2017) “Consent and engagement, security, and authentic living using wearable and mobile health technology”, Nature Biotechnology, 35 (7),617-620.

Kreitmair,K. andKruse, K. (2017) “Practical Implications of the Minimally Conscious StateDiagnosis in Adults”, CambridgeQuarterly, “Clinical Neuroethics”, Vol. 26, No. 4, 628-639.

Kreitmair,K.,(2016). “Memory Manipulation in the Context of Punishment and Atonement”, American Journal of Bioethics - Neuroscience,7 (4), 238-240.

Kreitmair,K.,(2016). “Beyond Withdrawing and Withholding”, American Journal of Bioethics, 16 (7), 22-24.

Kreitmair,K.,(2016). “The Confidence Criterion in Big Neuroscience Authorship”, American Journal of Bioethics – Neuroscience,7 (1), 24-26.

Using Format